These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 31188744

  • 1. Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer.
    Mansour-Ghanaei F, Joukar F, Baghaee M, Sepehrimanesh M, Hojati A.
    Biomol Concepts; 2019 May 31; 10(1):82-90. PubMed ID: 31188744
    [Abstract] [Full Text] [Related]

  • 2. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
    Kikuchi S, Wada O, Miki K, Nakajima T, Nishi T, Kobayashi O, Inaba Y.
    Cancer; 1994 Jun 01; 73(11):2695-702. PubMed ID: 8194008
    [Abstract] [Full Text] [Related]

  • 3. Serum pepsinogen in screening for gastric cancer.
    Kodoi A, Yoshihara M, Sumii K, Haruma K, Kajiyama G.
    J Gastroenterol; 1995 Aug 01; 30(4):452-60. PubMed ID: 7550854
    [Abstract] [Full Text] [Related]

  • 4. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
    Juan Cai W, Yin L, Kang Q, Chen Zeng Z, Liang Wang S, Cheng J.
    Sci Rep; 2017 Mar 02; 7():43536. PubMed ID: 28251999
    [Abstract] [Full Text] [Related]

  • 5. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
    Huang SC, Miki K, Furihata C, Ichinose M, Shimizu A, Oka H.
    Clin Chim Acta; 1988 Jun 30; 175(1):37-50. PubMed ID: 3168282
    [Abstract] [Full Text] [Related]

  • 6. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH, Zhang XH, Huang B, Wang JL, Mi JM, Shen HT, Zhang ZG, Yan X, Xing LX, Wang SJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct 30; 27(10):840-4. PubMed ID: 17343174
    [Abstract] [Full Text] [Related]

  • 7. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S, Hoon Lee J, Soo Park Y, Ok Kim S, Young Choi J, Yong Ahn J, Hoon Kim D, Don Choi K, June Song H, Hyug Lee G, Choe J, Jin Jang S, Jung HY.
    Scand J Gastroenterol; 2016 Oct 30; 51(2):137-44. PubMed ID: 26513345
    [Abstract] [Full Text] [Related]

  • 8. Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.
    Sadjadi A, Yazdanbod A, Lee YY, Boreiri M, Samadi F, Alizadeh BZ, Islami F, Fyfe V, Babaei M, Namazi MJ, Going JJ, Sotoudeh M, de Bock GH, Malekzadeh R, Derakhshan MH.
    PLoS One; 2013 Oct 30; 8(9):e74440. PubMed ID: 24098650
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area.
    Gantuya B, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Uchida T, Yamaoka Y.
    Gastric Cancer; 2019 Jan 30; 22(1):104-112. PubMed ID: 29934751
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
    Aoki K, Misumi J, Kimura T, Zhao W, Xie T.
    J Epidemiol; 1997 Sep 30; 7(3):143-51. PubMed ID: 9337512
    [Abstract] [Full Text] [Related]

  • 11. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI, de Aretxabala U X, Santander D R, Sabah T S, Maira S J, Navarro R A, Planzer D M, Gómez L F, Etchart M, Gallegos I, Torrens X, Fasce P G, Reydet I.
    Rev Med Chil; 2007 Dec 30; 135(12):1519-25. PubMed ID: 18357351
    [Abstract] [Full Text] [Related]

  • 12. Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.
    Konishi N, Matsumoto K, Hiasa Y, Kitahori Y, Hayashi I, Matsuda H.
    J Clin Pathol; 1995 Apr 30; 48(4):364-7. PubMed ID: 7615858
    [Abstract] [Full Text] [Related]

  • 13. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP, Gong YH, Wang L, Gong W, Yuan Y.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 31; 86(40):2826-30. PubMed ID: 17200016
    [Abstract] [Full Text] [Related]

  • 14. Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.
    Begum A, Baten MA, Begum Z, Ahsan MM, Rahman SF, Chowdhury F, Khan AH.
    Mymensingh Med J; 2017 Jul 31; 26(3):628-634. PubMed ID: 28919620
    [Abstract] [Full Text] [Related]

  • 15. Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
    Parthasarathy G, Maroju NK, Kate V, Ananthakrishnan N, Sridhar MG.
    Trop Gastroenterol; 2007 Jul 31; 28(4):166-70. PubMed ID: 18416347
    [Abstract] [Full Text] [Related]

  • 16. Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis.
    Sanduleanu S, Bruïne AD, Biemond I, Stridsberg M, Jonkers D, Lundqvist G, Hameeteman W, Stockbrügger RW.
    Eur J Clin Invest; 2003 Feb 31; 33(2):147-54. PubMed ID: 12588289
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F, Roshandel G, Semnani S, Ahmadi A, Faghani B, Besharat S, Akhavan-Tabib A, Amiriani T.
    Asian Pac J Cancer Prev; 2014 Feb 31; 15(17):7433-6. PubMed ID: 25227854
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
    Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, Ooms EC, Kreuning J, Kostense PJ, Eriksson AW.
    Cancer; 1987 Mar 01; 59(5):952-8. PubMed ID: 3815274
    [Abstract] [Full Text] [Related]

  • 19. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH, Huang B, Wang JL, Li YH, Mi JM, Shen HT, Zhang ZG, Yan X, Xing LX, Wang SJ.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):507-11. PubMed ID: 17147114
    [Abstract] [Full Text] [Related]

  • 20. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Jul 01; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.